Evidence map›Paper›PMID 40318386›Full record

ReviewMolecular pharmacology2025

Non-nutritive sweeteners in food-drug interactions: An overview of current evidence.

Laura Danner, Kale Kroenke, Stephanie Olivier-Van Stichelen

Abstract readReview
In one paragraph

Review in Molecular pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Laura DannerDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin.
Kale KroenkeDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin; Rowan University, Glassboro, New Jersey.
Stephanie Olivier-Van StichelenDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin; Department of Obstetrics & Gynecology, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: solivier@mcw.edu.

Funding

Placental Hormones and O-GlcNAcylation in Gestational DiabetesR01HD104808 · NICHD · MEDICAL COLLEGE OF WISCONSIN · PI Stephanie Olivier-Van Stichelen · 2022 to 2026
$1.8M
NICHD NIH HHS R01 HD104808
6 · The paper itself

Abstract

Food-drug interactions occur when the presence of foods interferes with the absorption, distribution, metabolism, or excretion of pharmaceuticals. Specific compounds within foods, like certain phytochemicals from grapefruit, have been known to precipitate food-drug interactions for decades, leading to guidance from physicians and pharmacists about patients' dietary restrictions while taking certain drugs. Although approved by the Food and Drug Administration, high-intensity non-nutritive sweeteners (NNS) share qualities with drugs that suggest the potential for similar interactions. In this minireview, we have reviewed 5 of the most popular NNS, including saccharin, aspartame, acesulfame potassium, sucralose, and stevia, and detail their drug-like qualities, regulatory status, pharmacokinetics, and primary research articles containing evidence of NNS interacting with drug absorption, distribution, metabolism, and excretion. Although studies varied widely in concentration ranges for NNS, model systems, and methods, all NNS included in this review were found to have known interactions with mediators of absorption, distribution, metabolism, and excretion from studies conducted after their Food and Drug Administration approval or generally recognized as safe designation. We have highlighted essential gaps in the literature and recommend the scientific community actively research NNS as food additives that may interact with drugs. SIGNIFICANCE STATEMENT: Food-drug interactions are a growing concern in Western societies where polypharmacy and ultraprocessed foods and beverages are increasingly common. High-intensity non-nutritive sweeteners bear structural similarities to pharmaceuticals, and evidence suggests they interact with mediators of drug pharmacokinetics. This minireview highlights the interactions uncovered thus far and serves as a call to action for the scientific community to establish rigorous, consistent testing that will enable updated safety guidelines for consumers.

Indexed as

Food-Drug InteractionsNon-Nutritive SweetenersSweetening AgentsAnimalsAspartameHumansSaccharinSucroseThiazinesacetosulfameAspartameNon-Nutritive SweetenersSaccharinSucroseSweetening AgentsThiazinesFood-drug interactionsNon-nutritive sweetenersNutritionPharmacologyToxicology

Identifiers

PMID40318386
PMCPMC13632074

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.